[Tamoxifen therapy in previously treated female patients].
We did a pilot study in 35 pretreated cases with disseminated metastatic breast cancer. These patients got a therapy of about 20 mg/day. We evaluated objective remissions, but also subjective responses. In good correlation to similar trials we found benefits in 35%.